晶泰控股（02228）今日盘中大涨8.13%，引起市场广泛关注。截至上午10:25，该股已成为港股市场中表现最为亮眼的股票之一。
消息面上，晶泰控股于今日上午10:15出现大手买入，成交量为94.2万股，成交价为港币9.77元，涉资920.334万港元。这笔大额交易显示出机构投资者对晶泰控股的强烈信心，可能是推动股价上涨的重要因素之一。截至上午10:25，晶泰控股股价已达到港币10.18元的日内高点，总成交量达1.372亿股，总成交金额高达13.392亿港元，显示出极高的市场活跃度。
值得注意的是，今日港股创新药概念股整体表现强劲。除晶泰控股外，歌礼制药-B（01672）涨超7%，先声药业（02096）和中国生物制药（01177）均涨超5%。这一趋势表明投资者对创新药行业前景持乐观态度，也为晶泰控股的股价上涨提供了有利的市场环境。作为创新药概念股的代表之一，晶泰控股的强势表现反映了市场对其研发能力和未来发展潜力的认可。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.